Boosting CAR T Cell Therapy for Solid Tumors

Katie McKenna will discuss how oncolytic viral therapy enhances CAR-T cell killing of cancer cells.

The Scientist Creative Services Team in Collaboration with IsoPlexis
Apr 5, 2021

FREE Webinar

Tuesday, April 27, 2021
2:30 - 3:30 PM, Eastern Time

Register Now

Chimeric antigen receptor (CAR) T cells hold great promise for targeting and fighting cancer. However, their efficacy in solid tumors has been below expectations, as the tumor microenvironment (TME) limits their infiltration and produces a range of immune-inhibitory molecules to deactivate T cells. Researchers are developing new strategies to enhance CAR-T cell therapy for solid tumors by disrupting the TME and promoting T cell persistence. In this webinar brought to you by IsoPlexis, Katie McKenna will discuss how she uses CAR-T cells in combination with mesenchymal stromal cells that deliver engineered adenoviruses to stimulate the immune response in the TME.  

Topics to be covered

  • Targeting non-small cell lung cancer using a cell carrier system to deliver an oncolytic and immunostimulatory adenovirus
  • Efficacy of oncolytic virotherapy in 3D cell culture and in vivo
  • Assessing T cell functionality with single-cell proteomics

Register Now

Meet the speaker

Katie McKenna, PhD
Postdoctoral Fellow
Center for Cell and Gene Therapy
Baylor College of Medicine
Texas Children’s Hospital
Methodist Hospital

May 2021

Animal Hybrids

Mating between different species may drive evolution


Sponsored Product Updates

Coupling Machine Learning and Flow Cytometry
Machine learning unleashes the untapped potential of modern flow cytometry
Generating Ultrapure Water
High-quality water produces optimal results for a variety of laboratory applications.
Producing Publication Worthy Western Blots
Obtain highly quantitative data that is impossible to misrepresent.
Precise Spatial Phenotyping with ChipCytometry Reveals Rare Cells
Researchers identified an uncommon B cell subset associated with autoimmunity.